Journals / Glokom Katarakt / 2007 / Cilt: 2 - Sayı: 1

Acute bilateral angle closure glaucoma secondary to topiramate use

Topiramat kullanımına bağlı gelişen akut bilateral açı kapanması glokomu

Pages
67–69
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Due to the potential ophthalmic side effects of topiramate, patients should be warned prior to drug initiation.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:A case, which presents with acute bilateral angle-closure glaucoma and acute myopia, was seen at our clinic.
📊
Key Findings & Data:Patient had no prior history of glaucoma and/or any other ocular abnormalities but had a history of secondary generalized epilepsy and was started with topiramate acetate 10 days prior to admission.
💡
Conclusion & Impact:Due to the potential ophthalmic side effects of topiramate, patients should be warned prior to drug initiation.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Kadın · Orta yaşlı · Glokom

Abstract

A case, which presents with acute bilateral angle-closure glaucoma and acute myopia, was seen at our clinic. Patient had no prior history of glaucoma and/or any other ocular abnormalities but had a history of secondary generalized epilepsy and was started with topiramate acetate 10 days prior to admission. Patient’s signs and symptoms responded well to topiramate discontinuation, topical and systemic anti glaucomatous medications and topical cycloplegic agents. In the follow-up period, visual acuity, intraocular pressure, gonioscopic and A-scan ultrasonographic findings returned to normal. Due to the potential ophthalmic side effects of topiramate, patients should be warned prior to drug initiation.

Özet

Bilateral açı kapanması glokomu ve akut miyopi gelişen olgu kliniğimize başvurdu. Hastanın özgeçmişinde glokom ve/veya başka oküler sorun bulunmamasına karşın, ikincil jeneralize epilepsi nedeniyle 10 gün önce topiramat asetat tedavisi başlanmıştı. Topiramat tedavisi kesilen ve topikal ve sistemik antiglokomatöz ajanlar ile topikal sikloplejik tedavisi başlanan hastanın şikayet ve semptomları kayboldu. Hastanın takiplerinde, görme keskinliği, göz içi basıncı, Ascan biometrik ve gonyoskopik bulguları normale döndü. Topiramatın bu olası oftalmik yan etkileri nedeniyle, hastalar ilaç öncesinde bilgilendirilmeli ve uyarılmalıdır.

🔖

Cite This Article

ALTIPARMAK, U. E., HAMURCU, A. G., YILMAZ, İ. A., ŞATANA, S. B., DUMAN, S. (2007). Acute bilateral angle closure glaucoma secondary to topiramate use. Glokom Katarakt, Cilt: 2 - Sayı: 1, 67–69. https://ajindex.com/articles/226658

References (9)

  1. Ikeda N, Ikeda T, Nagata M.: Ciliochoroidal effusion syndrome induced by su İfa derivatives Arch Ophtalmol. 2002;120:1775. Thambi L, Kapcala LR Chambers W.: Topiramate-associated se­ condary angle-closure glaucoma: a case series. Arch Ophtalmol. 2002;120:1108. Fraunfelder FW, Fraunfelder FT, Edwin U.: Topiramate-associated acute, bilateral, secondary angle-closure glaucoma. Ophtalmo- logy. 2004;111:109-111.
  2. Banta JT, Hoffmn K, Budenz DL: Presumed topiramate indu­ ced bilateral acute angle closure glaucoma. Am J Ophtalmol. 2001;132:112-114.
  3. Boentert M, Aretz H, Ludemann P.: Acute myopia and angle closure glaucoma induced by topiramate. Neurology. 2003; 11;61:1306. Chen TC, Chao CW, Sorkin JA.: Topiramate induced myopic shift and angle closure glaucoma. Br J Ophtalmol. 2003;87:648- 649. Medeiros FA, Zhang XY, Bernd AS, et al.: Angle-closure glaucoma associated with ciliary body detachment in patients using topira­ mate. Arch Ophtalmol. 2003;121:282-285.
  4. Rhee DJ, Goldberg MJ, Parrish RK.: Bilateral angle closure gla­ ucoma and ciliary body swelling from topiramate. Arch Ophtal­ mol. 2001;119:1721-1 723. Sankar PS, Pasquale KR, Grosskreutz CL: Uveal effusion and se­ condary angle closure glaucoma associated with topiramate use. Arch Ophtalmol. 2001;119:1210-1211.
  5. Craig JE, Ong TJ, Louis DL.: Mechanism of topiramate-induced acute-onset myopia and angle closure glaucoma. Am J Ophtal­ mol.2004;137:193-195.
  6. Bovino JA, Marcus FF.: The mechanism of transient myopia in­ duced by sulfonamide therapy. Am J Ophthalmol. 1982;94:99- 101. Sankar PS, Pasquale LR, Grosskreutz CL.: Uveal effusion and se­ condary angle-closure glaucoma associated with topiramate use. Arch Ophthalmol. 2001;119;1210-1211.
  7. Medieros FA, Zhang XY, Bernd AS, et al.: Angle-closure glaucoma associated with ciliary body detachment in patients using topira­ mate. Arch Ophthalmol. 2003;121;282-284.
  8. Hook SR, Holladay JT, Prager TC, et al.: Transient myopia indu­ ced by sulfonamides. Am J Ophthalmol. 1986;101:195-196.
  9. Kimura R, Kasai M, Shoji K, et al.: Swollen ciliary process as an initial symptom in Vogt-Koyanagi-Harada syndrome. Am J Oph­ thalmol. 1983;95:402-403.